Multiple Sclerosis Trial, Recruiting NCT06511154 Sponsor: Ankara Yildirim Beyazıt University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06511154
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 65 years old
  • People who have been formally diagnosed with Multiple Sclerosis (MS) by a neurologist
  • People whose MS-related disability is below a certain level, as measured by a standard scale called the EDSS (a score below 5.5) (confirm with trial site)
  • People who scored 24 or above on a standard memory and thinking test called the Mini Mental Test, indicating no significant cognitive problems
  • People who have completed at least primary school education
  • People whose MS medication has not changed in the last 6 months
  • People who have not had an MS attack in the last 3 months and are not currently using high-dose steroid treatment
  • People who are volunteering to take part

Who may not be able to join:

  • People with hearing or vision difficulties that would make communication during the trial difficult
  • People who have another neurological or psychiatric condition (separate from MS) that affects memory or thinking
  • People who are pregnant
  • People who have a cancer diagnosis
  • People who have other ear balance disorders or bone and joint conditions that could affect their balance
  • People who are currently taking part in a different exercise therapy programme

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emine İpek Halatcı, MSc, Ankara Yildirim Beyazıt University

Phone: 05347708416

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara Yildirim Beyazıt University
Registry
ClinicalTrials.gov
Start date
13 May 2024
Est. completion
15 May 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Cognitive status; Upper extremity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov